Key takeaways:
There’s currently not enough research to show that cannabis (marijuana) can treat symptoms of Parkinson’s disease — or slow disease progression.
Some people report an improvement in their Parkinson’s disease symptoms with cannabis use. But these benefits aren’t seen in higher-quality research studies.
If you’re considering using cannabis to help treat Parkinson’s, it's important to understand the risks first. And it shouldn’t be used as a substitute for established treatments.
Parkinson’s disease affects almost every aspect of someone’s day-to-day life. But for many of the half a million people in the U.S. diagnosed with the condition, the available medications aren’t always enough to treat their symptoms.
So, it makes sense that people are exploring whether cannabis (also referred to as marijuana) can help treat their condition. So far, the research is mixed about the role of cannabis in Parkinson’s disease treatment.
It's not clear if cannabis can help people with Parkinson’s disease.
Support Made Simple: Enhance Care With Precise Daily Doses
Supporting a loved one with Parkinson’s disease? If you know someone who is taking the standard of care, carbidopa/levodopa, consider Dhivy® (carbidopa/levodopa). Affordable access to Dhivy® is made available through a partnership with GoodRx.
GoodRx Health information and resources are reviewed by our editorial staff with medical and healthcare policy and pricing experience. See our editorial policy for more detail. We also provide access to services offered by GoodRx and our partners when we think these services might be useful to our visitors. We may receive compensation when a user decides to leverage these services, but making them available does not influence the medical content our editorial staff provides.
Prescribing Information I Important Safety Information 3354-V2 (v 2.1)
DHIVY is contraindicated in patients
•Currently taking a nonselective monoamine oxidase (MAO) inhibitor (e.g., phenelzine, linezolid, and tranylcypromine) or have recently (within 2 weeks) taken a nonselective MAO inhibitor. Hypertension can occur if these drugs are used concurrently.
•With known hypersensitivity to any component of DHIVY.
Taking DHIVY may result in falling asleep while engaged in normal activities, even without warning and as late as 1 year or later after starting DHIVY. This may affect your ability to drive or operate machinery, resulting in accidents. Do not do anything that requires alertness until you know how DHIVY affects you. Tell your healthcare provider about any sleep medicines you take or if you have a sleep disorder, and discuss any episodes of drowsiness or sleepiness you experience while taking DHIVY.
Talk to your healthcare provider before you change the dose or stop taking DHIVY, as this may result in serious side effects. Call your healthcare provider immediately if you develop withdrawal symptoms such as fever, confusion, or severe muscle stiffness.
Tell your healthcare provider if you have any heart conditions, especially if you have had a heart attack or irregular heartbeats. Your heart function should be monitored during the time period your DHIVY dose is first adjusted.
Treatment with DHIVY may cause hallucinations or abnormal thoughts and behaviors. Be sure to tell your healthcare provider if you experience excessive suspicion; seeing, hearing, or feeling things that are not real; confusion; agitation; aggressive behavior; and disorganized thinking.
Treatment with DHIVY may also cause intense urges to gamble, increased sexual urges, intense urges to spend money, binge eating, and other intense urges, as well as the inability to control those urges. Uncontrolled sudden movements of the face, arms, legs, or trunk may appear or get worse during treatment with DHIVY. This may mean your dosage of DHIVY or other Parkinson’s medications needs to be adjusted.
Tell your healthcare provider if you have ever had a peptic ulcer or glaucoma, as treatment with DHIVY may worsen these conditions. DHIVY also may cause abnormal blood or urine test results.
Some patients taking DHIVY may experience depression or suicidal thoughts. Tell your healthcare provider if you have thoughts of suicide.
The most common side effects that may appear with DHIVY include uncontrolled sudden movements and nausea.
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using DHIVY with certain other medicines, including MAO inhibitors, isoniazid, iron supplements, medicines for high blood pressure or those that increase or decrease dopamine levels, or metoclopramide, may cause serious side effects.
Notify your healthcare provider if you become pregnant or intend to become pregnant during DHIVY therapy or if you intend to breastfeed or are breastfeeding an infant.
Please see full Prescribing Information.
People have reported that cannabis helps reduce symptoms such as tremor, slow movement, and pain. And early research suggests that cannabis may help Parkinson’s disease. However, experts are waiting on large-scale clinical trials to better understand the potential benefit.
Given the way cannabis works in the body, it makes sense that it has potential to help with Parkinson’s. Cannabis contains active ingredients called cannabinoids. Two of the main ones are:
THC (tetrahydrocannabinol), which is responsible for the mind-altering and mood-enhancing effects of cannabis
CBD (cannabidiol), which has anti-inflammatory properties that help relieve symptoms of pain and anxiety
Cannabinoids bind to receptors throughout the body, especially in the brain and nervous system. These receptors play an important role in things like mood, thinking, and movement. So it’s no surprise that people are using it for a variety of neurological disorders — from traumatic brain injury to multiple sclerosis. And it’s possible that the anti-inflammatory effect of certain cannabinoids could have a role in treating Parkinson’s disease.
Parkinson’s is caused by the death of neurons in a specific part of the brain. This part of the brain also contains many of the receptors bound by cannabinoids. And some researchers think that cannabis’s effect on these receptors might help protect brain cells from damage.
Some studies have found encouraging results. But the Parkinson’s Foundation doesn’t currently recommend people use cannabis to treat their symptoms or slow disease progression. Part of the reason for this recommendation is that there isn’t enough research to draw any firm conclusions yet.
The pros and cons of cannabis: Learn about the potential health benefits and safety risks of cannabis as a medical treatment.
How does weed affect the brain? Long-term use of cannabis can have lasting effects on brain function and mood.
Safe cannabis use: If you’re considering trying cannabis to treat a medical condition, it's important to know how to do so safely.
When experts look at all the available research on the effects of cannabis on Parkinson’s disease, they all come to a similar conclusion — we need more information. Even though there are smaller studies that do report improved symptoms with cannabis use, researchers agree these studies don't meet high enough quality standards.
The main concerns with these studies are that they’re:
Small: Only a few participants were in the study.
Not controlled: This means there’s no comparison group that receives a placebo instead of cannabis. And cannabis isn’t compared to existing treatments for Parkinson’s.
Open label: This means both the researchers and the participants know they’re receiving cannabis. So the results are highly prone to bias.
Not standardized: The studies lacked any sort of standardized cannabis dosing or treatment protocol.
This doesn’t mean cannabis has no future role in Parkinson's treatment. It means researchers need to conduct more studies.
As mentioned in the previous section, cannabis has positive effects on the brain that may impact Parkinson’s disease. And there are studies in lab and animal models that suggest cannabis may help with:
Motor (movement) symptoms, like tremors and rigidity
Non-motor symptoms, like mood and pain
Movement side effects related to prescription medications that treat Parkinson’s
In small, non-controlled studies, people with Parkinson's do report improvement in their symptoms with cannabis use. These symptoms include:
Tremors
Rigidity
Slow movements
Sleep
Pain
A survey study found that about half of people with Parkinson's report symptom improvement with cannabis. Another survey study found that people with Parkinson's mainly used cannabis for anxiety, pain, and sleep. But about 1 in 4 users also stopped taking cannabis because their symptoms hadn’t improved.
So even the anecdotal reports are a bit mixed. But it’s likely these mixed results are also related to:
The variation in symptoms from person to person
Someone’s stage of Parkinson’s disease
The dose, form, and frequency of cannabis use
Like any medication or treatment, it's important to be aware of the risks associated with cannabis use. These include:
Side effects
Toxicity (possible overdose)
Dependence (needing to continue using cannabis)
Medication interactions
Below, we’ll go into each risk in more detail.
Cannabis may cause unwanted side effects that include:
Difficulty thinking
Short-term memory loss
Dizziness
Blurred vision
Problems with balance and coordination
Long-term or frequent use of cannabis may also increase your risk of:
Lung damage — from inhaled cannabis products —that can lead to conditions like COPD (chronic obstructive pulmonary disease)
Heart disease and heart attacks
Stroke
Cannabinoid hyperemesis syndrome, a condition that causes uncontrollable vomiting
Anxiety and depression
It's possible to overdose on cannabis, although it’s not typically a life-threatening issue. An overdose is more likely with edible products. That’s because edibles’ effects can start and last in unpredictable ways. For example, it can take as long as 2 to 4 hours to notice the effects. And these effects can then last up to 6 to 8 hours. So it's easy for people to think they need a higher dose and end up taking too much.
It's less common to overdose on cannabis when you smoke it, but it's still possible. This is especially the case with cannabis products that contain a high amount of THC compared to CBD. High doses of THC can lead to:
Agitation, anxiety, or paranoia
Hallucinations
Psychosis
Chest pain or rapid heart rate
Nausea and vomiting
Seizure
Repeated cannabis use can lead to dependence. This is when you need to continue using a substance in order to function. And sometimes, this dependence can lead to misuse. This is called cannabis use disorder. Research estimates that about a third of people who use cannabis experience dependence.
Most (but not all) people who use cannabis heavily will experience withdrawal symptoms when they cut back. These symptoms include:
Sleep problems or insomnia
Loss of appetite
Anxiety
Strong cravings
Cannabis is processed in the liver. This process uses similar enzymes that the body uses to break down other medications. This means that when cannabis and other medications are in the body at the same time, the liver may have a hard time processing them both. This can lead to:
Increased risk of unwanted side effects from cannabis
Toxic levels of medications
Decreased effectiveness of other medications
If you take any medications that interact with grapefruit, there’s a chance they may interact with cannabis too. This is why it's important to discuss cannabis use with your primary care provider. They can help you figure out if it's affecting your other medications and how to adjust your medications to make it safer for you.
Medical cannabis is legal in 38 states, the District of Columbia, and three U.S. territories. Of these, 17 states consider Parkinson’s disease a qualifying condition for medical cannabis use. Most states also include severe muscle spasms and chronic pain as qualifying conditions, which are often symptoms associated with Parkinson’s.
If you’re thinking about using cannabis to treat your Parkinson’s symptoms, talk to your healthcare team first. They can help you weigh the benefits and risks unique to your condition and current treatment plan. You should also only purchase cannabis products from a licensed dispensary to ensure their quality and safety is regulated.
Since there’s no standard dose of cannabis for Parkinson’s, it’s best to err on the side of caution:
Begin with a low dose. If you need to, you can gradually increase it over several days or weeks.
Avoid cannabis products with high doses of THC. Since THC specifically can lead to issues with thinking and balance, high doses could potentially worsen symptoms of PD.
For edibles, beverages, and tinctures, start with 1 mg to 2.5 mg of THC.
For smoked or vaporized cannabis, start with one puff, and wait 15 minutes before taking another one. Look for inhalable products with a few milligrams of THC or a low percentage of THC.
It’s also helpful to look for high-CBD cannabis or products with a balanced ratio of CBD to THC. CBD can help reduce some of the unwanted side effects of THC and have benefits of its own.
More and more people are exploring the potential benefits of cannabis for Parkinson’s disease. The current research shows that cannabis has some promise, but we don’t have enough research to know if it’s safe or effective for Parkinson’s. And cannabis comes with physical and mental health risks. If you’re living with Parkinson’s disease and are interested in seeing if cannabis can help, speak to a healthcare professional you know and trust. They can help you do so in the safest way possible.
If you or someone you know struggles with substance use, help is available. Call SAMHSA’s National Helpline at 1-800-662-HELP (4357) to learn about resources in your area.
Keep in mind that cannabis is legal in some states for recreational and/or medicinal use, but not in others. Cannabis is still illegal under federal law. Before you use cannabis products, find out the laws in your state.
Babayeva, M., et al. (2016). Marijuana compounds: A nonconventional approach to Parkinson's disease therapy. Parkinson's Disease.
Bougea, A., et al. (2020). Medical cannabis as an alternative therapeutics for Parkinson’s disease: Systematic review. Complementary Therapies in Clinical Practice.
Doohan, P. T., et al. (2021). Cannabinoid interactions with cytochrome P450 drug metabolism: A full-spectrum characterization.
Feeney, M. P., et al. (2021). Weeding through the haze: A survey on cannabis use among people living with Parkinson’s disease in the US. npj Parkinson's Disease.
Jeffers, A. M., et al. (2024). Association of cannabis use with cardiovascular outcomes among US adults.
Kindred, J. H., et al. (2017). Cannabis use in people with Parkinson's disease and multiple sclerosis: A web-based investigation.
Kluger, B., et al. (2015). The therapeutic potential of cannabinoids for movement disorders. Movement Disorders.
Leehey, M. A., et al. (2020). Safety and tolerability of cannabidiol in Parkinson disease: An open label, dose-escalation study. Cannabis and Cannabinoid Research.
Lotan, I., et al. (2014). Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: An open-label observational study. Clinical Neuropharmacology.
National Conference of State Legislatures. (2024). State medical cannabis laws.
National Institute of Neurological Disorders and Stroke. (2023). Parkinson's disease: Challenges, progress, and promise.
Parkinson's Foundation. (2020). Parkinson’s Foundation consensus statement on the use of medical cannabis for Parkinson’s disease.
Patel, R. S., et al. (2019). Pros and cons of marijuana in treatment of Parkinson’s disease. Cureus.
Varshney, K., et al. (2023). Cannabinoids in treating Parkinson's disease symptoms: A systematic review of clinical studies. Cannabis and Cannabinoid Research.
Venderová, K., et al. (2004). Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms. Movement Disorders.
Yenilmez, F., et al. (2021). Cannabis in Parkinson’s disease: The patients’ view. Journal of Parkinson's Disease.
Zeng, L., et al. (2021). Values and preferences towards medical cannabis among people living with chronic pain: A mixed-methods systematic review. BMJ Open.